FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372488002: Dolasetron (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197781015 Dolasetron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211023010 Dolasetron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1197781015 Dolasetron (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1197781015 Dolasetron (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211023010 Dolasetron en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1211023010 Dolasetron en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
38741000188117 dolasétron fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
38741000188117 dolasétron fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron (substance) Is a 5-HT3 receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron (substance) Has disposition 5-HT3 receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron (substance) Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Dolasetron mesylate Is a False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dolasetron (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dolasetron mesilate 20 milligram/1 ampule powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate monohydr 50mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesylate monohydr 100mg/5 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dolasetron mesilate 200 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesilate 20mg/mL injection solution 0.625mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Dolasetron mesilate 20mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dolasetron in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dolasetron-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dolasetron mesylate Is modification of (attribute) True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only dolasetron (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dolasetron only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dolasetron only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Dolasetron (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start